BioNexus Gene Lab Corp Common stock (BGLC) short interest & short volume · 9K shares short
BioNexus Gene Lab Corp Common stock official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
BGLC short interest fell 10.5% to 9K shares in the Oct 15, 2026 report (1.0 days to cover). Daily short volume averaged 35.0% of volume over the last 20 sessions, down from 41.5% the 20 sessions before, the 30th percentile of its own 20-day averages since Sep 22, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 9K
- prior 10K
- % of float
- —
- no float on file
- Days to cover
- 1.0
- avg vol 13K
- Change vs prior report
- -10.5%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 2)
- 38.8%
- 8K of 21K
- 20-day average
- 35.0%
- prior 41.5%
- Percentile vs own history
- 30th
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026
Short squeeze score (model)
Price since settlement: -22.2%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
BGLC's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · BGLC overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-02 | 8,074 | 20,793 | 38.8% |
| 2026-10-30 | 671 | 4,235 | 15.8% |
| 2026-10-29 | 1,015 | 2,437 | 41.6% |
| 2026-10-28 | 798 | 2,738 | 29.1% |
| 2026-10-27 | 1,034 | 2,441 | 42.4% |
| 2026-10-26 | 97 | 466 | 20.8% |
| 2026-10-23 | 993 | 1,476 | 67.3% |
| 2026-10-22 | 68 | 733 | 9.3% |
| 2026-10-21 | 249 | 557 | 44.7% |
| 2026-10-20 | 803 | 864 | 92.9% |
Materials peers with similar quant ratings
BGLC among 146 rated Materials stocks (Lician quant rating, Nov 4, 2026). How the rating works
- ERO short interest4.99 · Strong Buy
- FRD short interest4.96 · Strong Buy · stock
- AU short interest4.93 · Strong Buy
- SCCO short interest4.90 · Strong Buy · stock
- HMY short interest4.88 · Strong Buy
- IAG short interest4.85 · Strong Buy
- CF short interest4.82 · Strong Buy · stock
- NUE short interest4.79 · Strong Buy · stock
BGLC short interest FAQ
What is BGLC's short interest?
BioNexus Gene Lab Corp Common stock (BGLC) had 9K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.
How many days to cover does BGLC have?
1.0 days: 9K shares short divided by an average daily volume of 13K for the Oct 15, 2026 period.
Is BGLC short interest rising or falling?
BGLC short interest fell (-10.5%) from 10K to 9K shares in the Oct 15, 2026 report.
Is BGLC a short squeeze candidate?
Lician's squeeze watch scores BGLC 3 out of 100 (low) from the Oct 15, 2026 report: days to cover 2.5/25, change in short interest vs prior report 0/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of BGLC daily volume is sold short?
35.0% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 30th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was BGLC's latest FINRA short volume?
On Nov 2, 2026, cached FINRA short volume for BioNexus Gene Lab Corp Common stock (BGLC) was 8,074 shares, 38.8% of 20,793 total volume.
How many BGLC short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for BioNexus Gene Lab Corp Common stock (BGLC), from Oct 20, 2026 through Nov 2, 2026.
How did BGLC short volume percent change from the prior cached session?
Cached FINRA short volume for BioNexus Gene Lab Corp Common stock (BGLC) moved from 15.8% on Oct 30, 2026 to 38.8% on Nov 2, 2026, up 23.0 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.